Author

Lutz P. Müller

Observed name: Müller, Lutz P.

Institutions: University Hospital in Halle, Martin Luther University Halle-Wittenberg

Observed institutions: University Hospital in Halle, Martin Luther University Halle-Wittenberg

OpenAlex ID: A5126584569

What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation

2026 · Stefan W. Krause, Wolfgang Bethge, et al. · Annals of Hematology

Abstract 2440: Single-cell MRD profiling identifies CXCR4-high AML as a responder population to CXCR4 inhibition with Motixafortide

2026 · Enise Ceran, Sonia Jaramillo-Segura, et al. · Cancer Research

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

2024 · Stelljes, Matthias, Middeke, Jan Moritz, et al. · The Lancet Haematology

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

2024 · Stelljes, Matthias, Middeke, Jan Moritz, et al. · RWTH Publications (RWTH Aachen)

Works count: 6

Citation count:

H-index:

I10-index: